Cargando…
Efficacy and Tolerability of Nintedanib in Idiopathic-Inflammatory-Myopathy-Related Interstitial Lung Disease: A Pilot Study
Objectives: To initially clarify the efficacy and tolerability of nintedanib in patients with idiopathic-inflammatory-myopathy-related interstitial lung disease (IIM-ILD). Methods: A retrospective, real-world analysis was conducted in IIM-ILD patients who regularly received outpatient visit or hospi...
Autores principales: | Liang, Junyu, Cao, Heng, Yang, Yang, Ke, Yini, Yu, Ye, Sun, Chuanyin, Yue, Lihuan, Lin, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886679/ https://www.ncbi.nlm.nih.gov/pubmed/33614683 http://dx.doi.org/10.3389/fmed.2021.626953 |
Ejemplares similares
-
Acute Exacerbation of Interstitial Lung Disease in Adult Patients With Idiopathic Inflammatory Myopathies: A Retrospective Case-Control Study
por: Liang, Junyu, et al.
Publicado: (2020) -
Predictors of progression in idiopathic inflammatory myopathies with interstitial lung disease
por: Cao, Heng, et al.
Publicado: (2022) -
The lungs were on fire: a pilot study of (18)F-FDG PET/CT in idiopathic-inflammatory-myopathy-related interstitial lung disease
por: Liang, Junyu, et al.
Publicado: (2021) -
Community-Acquired Pneumonia and Hospital-Acquired Pneumonia in Adult Patients with Idiopathic Inflammatory Myopathy: Outcome and Antibiotic Therapy
por: Liang, Junyu, et al.
Publicado: (2020) -
Talaromycosis in a Patient on Nintedanib for Interstitial Lung Disease
por: Madgula, Anantha Sriharsha, et al.
Publicado: (2020)